SAN DIEGO, October 24, 2014 – Profil Institute for Clinical Research, Inc., an early phase clinical research organization (CRO) focused on diabetes and obesity, celebrates its 10th year as a corporate sponsor of San Diego’s Step Out: Walk to Stop Diabetes, hosted by the American Diabetes Association (ADA).
The ADA’s Step Out Walk raises nearly $20 million annually with more than 150 walks taking place in 125 cities nationwide. The Step Out Walk in San Diego will take place Sunday, November 2 at De Anza Cove on Mission Bay. More information can be found at ADA’s Step Out homepage or to join or support Profil Institute’s team of walkers, please visit Profil Institute’s Step Out team homepage.
“Profil Institute is a supporter of the American Diabetes Association in every manner possible. We have the common goal of advancing research and finding better treatments to eradicate diabetes,” said Dr. Marcus Hompesch, Profil Institute President and CEO. “The Step Out Walk is a spectacular event and is our opportunity to sponsor and volunteer for an event benefiting the American Diabetes Association while walking side by side with the very people for whom our clinical research will hopefully make a significant impact.”
About Profil Institute for Clinical Research, Inc.
Profil Institute for Clinical Research, Inc. is a science driven, early phase clinical research organization (CRO) focused on diabetes and obesity. It is renowned for its scientific expertise, depth of services, expanded scope of research methodologies, and experience with every clinically relevant drug class in diabetes. The company provides end-to-end early phase services from consulting for strategic clinical development and regulatory planning through design and completion of complex clinical trials, including the reporting and publication of final study results.
Profil Institute’s expertise and experience encompasses small and large molecule therapies, biologics and biosimilars through all routes of administration, as well as devices. The company’s clients range from large pharma and drug discovery companies to small virtual companies throughout the Americas, Europe and Asia.
Profil Institute is also recognized internationally as an innovator of methodologies to improve the quality of metabolic research, including its Automated Glucose Clamp technology. As the leading early phase CRO focused on diabetes and obesity, Profil Institute is driving new, higher standards in metabolic clinical research through collaborative science with key academic and industry partners and its Metabolic Research Partners™ program.
Please visit www.profilinstitute.com.
For further information, please contact: